Acumen Pharmaceuticals, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Acumen Pharmaceuticals, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Acumen Pharmaceuticals, Inc. Assets for the quarter ending September 30, 2024 was $267M, a 6.77% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$267M	-$19.4M	-6.77%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$289M	+$112M	+62.9%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$301M	+$113M	+60.2%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$310M	+$114M	+57.8%	Dec 31, 2023	10-Q	2024-11-12
Q3 2023	$286M	+$83.1M	+40.9%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$177M	-$34.3M	-16.2%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$188M	-$32.2M	-14.6%	Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$197M	-$33.7M	-14.7%	Dec 31, 2022	10-K	2024-03-26
Q3 2022	$203M	-$31.6M	-13.4%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$212M	+$139M	+190%	Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$220M			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$230M	+$186M	+418%	Dec 31, 2021	10-K	2023-03-27
Q3 2021	$235M			Sep 30, 2021	10-Q	2021-11-15
Q2 2021	$72.9M			Jun 30, 2021	10-Q	2021-08-16
Q4 2020	$44.4M			Dec 31, 2020	10-K	2022-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.